Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424. Article

Bell, Erica Hlavin, Pugh, Stephanie L, Fisher, Barbara Jean et al. (2020). Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424. . JOURNAL OF CLINICAL ONCOLOGY, 38(15_suppl), 2518-2518. 10.1200/jco.2020.38.15_suppl.2518

cited authors

  • Bell, Erica Hlavin; Pugh, Stephanie L; Fisher, Barbara Jean; Lesser, Glenn Jay; Macdonald, David R; Fleming, Jessica L; McElroy, Joseph P; Becker, Aline P; Rogers, C Leland; Doyle, Thomas J; Werner-Wasik, Maria; Bahary, Jean-Paul; Yu, Michael; D'Souza, David; Laack, Nadia N; Sneed, Patricia Penny; Kwok, Young; Howard, Steven P; Mehta, Minesh P; Chakravarti, Arnab

authors

publication date

  • May 20, 2020

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 2518

end page

  • 2518

volume

  • 38

issue

  • 15_suppl